Nrupen Bhavsar, PhD

Assistant Professor in Medicine
Assistant Professor in Biostatistics and Bioinformatics
Associate of the Duke Initiative for Science & Society
Campus mail 200 Morris St, 3rd Floor, Durham, NC 27710
Phone (919) 668-7211
Email address nrupen.bhavsar@duke.edu

I am a quantitative epidemiologist with methodological expertise in the design and analysis of observational studies that leverage data from cohort studies, registries, and the electronic health record (EHR). My background, training, and research is in the measurement and characterization of biomarkers, risk factors and treatment outcomes for chronic disease using real-world datasets. My primary research interests are in the use of novel sources of data, including the EHR, to conduct chronic disease research at the intersection of informatics, biostatistics, and epidemiology. My ongoing work aims to integrate informatics, epidemiology, and biostatistics to reduce the burden of chronic disease. I have topical expertise in multiple chronic diseases, including oncology, cardiovascular disease, and chronic kidney disease. In parallel, I have a portfolio of research that aims to understand the impact of social determinants of health, including dynamic neighborhood changes, such as gentrification, on the health of adults and children. 

Education and Training

  • Fellowship, Johns Hopkins University School of Medicine, 2011 - 2013
  • Fellowship, New York University School of Medicine, 2010 - 2011
  • Ph.D., Johns Hopkins University, 2010

Publications

Qin, Rosie, Adam Olson, Bhavana Singh, Samantha Thomas, Steven Wolf, Nrupen A. Bhavsar, Brent A. Hanks, Joseph K. Salama, and April K. S. Salama. “Safety and Efficacy of Radiation Therapy in Advanced Melanoma Patients Treated With Ipilimumab.” Int J Radiat Oncol Biol Phys 96, no. 1 (September 1, 2016): 72–77. https://doi.org/10.1016/j.ijrobp.2016.04.017.

PMID
27375168
Full Text

Harrison, Michael Roger, Nrupen Anjan Bhavsar, Steven Paul Wolf, Brian Addis Costello, Ulka N. Vaishampayan, Christos Kyriakopoulos, Walter Michael Stadler, et al. “Prospective front-line management patterns in the Real World Metastatic Renal Cell Cancer (MaRCC) Registry.” In Journal of Clinical Oncology, 34:e16097–e16097. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.e16097.

Full Text

Harrison, Michael Roger, Nrupen Anjan Bhavsar, Steven Paul Wolf, Brian Addis Costello, Ulka N. Vaishampayan, Christos Kyriakopoulos, Walter Michael Stadler, et al. “Deferred systemic therapy (DST) in the prospective metastatic renal cell cancer (MaRCC) registry.” In Journal of Clinical Oncology, 34:e16084–e16084. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.e16084.

Full Text

Howie, L. J., P. K. Marcom, D. L. Topping, J. Force, R. Emerson, N. A. Bhavsar, S. E. Abbott, M. Parks, H. S. Robins, and K. L. Blackwell. “Abstract P4-14-16: T-cell clonality increases after neoadjuvant treatment with trastuzumab and pertuzumab.” In Poster Session Abstracts. American Association for Cancer Research, 2016. https://doi.org/10.1158/1538-7445.sabcs15-p4-14-16.

Full Text

Kyriakopoulos, Christos, Michael Roger Harrison, Nrupen Anjan Bhavsar, Steven Paul Wolf, Brian Addis Costello, Walter Michael Stadler, Hans J. Hammers, et al. “Physician treatment selection in the prospective Metastatic Renal Cell Cancer (MaRCC) Registry.” In Journal of Clinical Oncology, 34:563–563. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.2_suppl.563.

Full Text

Harrison, Michael Roger, Nrupen Anjan Bhavsar, Steven Paul Wolf, Brian Addis Costello, Walter Michael Stadler, Hans J. Hammers, Ulka N. Vaishampayan, et al. “Front-line management patterns in the prospective metastatic renal cell cancer (MaRCC) registry.” In Journal of Clinical Oncology, 34:617–617. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.2_suppl.617.

Full Text

Costello, Brian A., Michael R. Harrison, Nrupen A. Bhavsar, Steven P. Wolf, Christos E. Kyriakopoulos, Walter M. Stadler, Hans Joerg Hammers, et al. “Physician treatment selection in the prospective metastatic renal cell cancer (MaRCC) registry.” In Bju International, 116:7–7. WILEY-BLACKWELL, 2015.

Scholars@Duke

Harrison, Michael R., Nrupen A. Bhavsar, Steve P. Wolf, Brian A. Costello, Walter M. Stadler, Hans Joerg Hammers, Ulka Vaishampayan, et al. “Front-line management patterns in the prospective metastatic renal cell cancer (MaRCC) registry.” In Bju International, 116:12–12. WILEY-BLACKWELL, 2015.

Scholars@Duke

Bhavsar, Nrupen A., Michael R. Harrison, Bradford R. Hirsch, Patricia Creel, Steve P. Wolf, Greg P. Samsa, Eric M. Richardson, Kathleen A. Johnson, Azah Borham, and Daniel J. George. “The metastatic renal cell carcinoma (MaRCC) Registry: a prospective academic and community-based study of metastatic renal cell cancer patients.” In Bju International, 116:3–4. WILEY-BLACKWELL, 2015.

Scholars@Duke

Olson, A. C., R. Qin, B. Singh, N. Bhavsar, S. Wolf, J. K. Salama, J. P. Kirkpatrick, and A. K. Salama. “Radiosurgery for Brain Metastases in Melanoma Patients Receiving Ipilimumab.” In International Journal of Radiation Oncology*Biology*Physics, 93:E88–E88. Elsevier BV, 2015. https://doi.org/10.1016/j.ijrobp.2015.07.771.

Full Text

Pages